NAT2 Genotype and Isoniazid Medication in Children

by Klaus Golka, Silvia Selinski
Published 2016-09-01

Increased risk of impaired treatment satisfaction among girls/women and young people with suboptimal HbA1c: Results of a nationwide type 1 diabetes study

by Anna Stahl-Pehe, Silvia Selinski, Christina Bächle, Joachim Rosenbauer
Published 2021-05-01

Editorial: Biomarkers in Drug Hypersensitivity

by José A. G. Agúndez, Silvia Selinski, Emanuela Corsini, Klaus Golka, Elena García-Martín
Published 2017-06-01

Distinct SNP combinations confer susceptibility to urinary bladder cancer in smokers and non-smokers.

by Holger Schwender, Silvia Selinski, Meinolf Blaszkewicz, Rosemarie Marchan, Katja Ickstadt, Klaus Golka, Jan G Hengstler
Published 2012-01-01

Correction: Distinct SNP Combinations Confer Susceptibility to Urinary Bladder Cancer in Smokers and Non-Smokers.

by Holger Schwender, Silvia Selinski, Meinolf Blaszkewicz, Rosemarie Marchan, Katja Ickstadt, Klaus Golka, Jan G Hengstler
Published 2015-01-01

Health-related quality of life and rates of toxicity after high-dose-rate brachytherapy in combination with external beam radiation therapy for high-risk prostate cancer

by Hui-Juan Huang-Tiel, Isabella Otto, Klaus Golka, Silvia Selinski, Stephan Koswig, Kathrin Bathe, Steffen Hallmann, Thorsten H. Ecke
Published 2020-05-01

Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Addi...

by Thorsten H. Ecke, Hui-Juan Huang-Tiel, Klaus Golka, Silvia Selinski, Berit Christine Geis, Stephan Koswig, Katrin Bathe, Steffen Hallmann, Holger Gerullis
Published 2016-11-01